1. Home
  2. YPF vs EXAS Comparison

YPF vs EXAS Comparison

Compare YPF & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YPF
  • EXAS
  • Stock Information
  • Founded
  • YPF 1977
  • EXAS 1995
  • Country
  • YPF Argentina
  • EXAS United States
  • Employees
  • YPF N/A
  • EXAS N/A
  • Industry
  • YPF Integrated oil Companies
  • EXAS Medical Specialities
  • Sector
  • YPF Energy
  • EXAS Health Care
  • Exchange
  • YPF Nasdaq
  • EXAS Nasdaq
  • Market Cap
  • YPF 13.3B
  • EXAS 10.7B
  • IPO Year
  • YPF 1993
  • EXAS N/A
  • Fundamental
  • Price
  • YPF $30.95
  • EXAS $51.91
  • Analyst Decision
  • YPF Buy
  • EXAS Strong Buy
  • Analyst Count
  • YPF 7
  • EXAS 20
  • Target Price
  • YPF $41.30
  • EXAS $70.26
  • AVG Volume (30 Days)
  • YPF 1.7M
  • EXAS 2.8M
  • Earning Date
  • YPF 08-08-2025
  • EXAS 07-30-2025
  • Dividend Yield
  • YPF N/A
  • EXAS N/A
  • EPS Growth
  • YPF N/A
  • EXAS N/A
  • EPS
  • YPF 3.61
  • EXAS N/A
  • Revenue
  • YPF $17,858,226,821.00
  • EXAS $2,828,128,000.00
  • Revenue This Year
  • YPF $19.30
  • EXAS $14.58
  • Revenue Next Year
  • YPF N/A
  • EXAS $12.75
  • P/E Ratio
  • YPF $8.68
  • EXAS N/A
  • Revenue Growth
  • YPF 131.82
  • EXAS 11.57
  • 52 Week Low
  • YPF $16.18
  • EXAS $39.97
  • 52 Week High
  • YPF $47.43
  • EXAS $72.83
  • Technical
  • Relative Strength Index (RSI)
  • YPF 38.90
  • EXAS 44.34
  • Support Level
  • YPF $30.45
  • EXAS $52.00
  • Resistance Level
  • YPF $33.20
  • EXAS $55.90
  • Average True Range (ATR)
  • YPF 1.39
  • EXAS 2.31
  • MACD
  • YPF -0.20
  • EXAS -0.04
  • Stochastic Oscillator
  • YPF 10.92
  • EXAS 24.90

About YPF YPF Sociedad Anonima

YPF SA is an Argentina-based integrated oil and gas company. It is engaged in operating a fully integrated oil and gas chain across the domestic upstream, downstream, and gas and power segments. Its upstream segment consists of exploration, development, and production of crude oil, natural gas, and LPG. Its downstream segment include refining, marketing, transportation, and distribution of oil and a wide range of petroleum products, petroleum derivatives, petrochemicals, LPG and bio-fuels. Gas and Power segment performs activities related to natural gas transportation to third parties and Downstream segment. Central Administration and Others includes activities performed by the Group not falling under the business segments. It generates maximum revenue from downstream segment.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: